Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection FractionMichael E. Nassif, John M. Cox, Darren K. McGuire et al.|Circulation|2019Cited by 427
2022 ACC/AHA/HFSA Guideline for the Management of Heart FailurePaul A. Heidenreich, Tanveer Rab, Biykem Bozkurt et al.|Journal of Cardiac Failure|2022Cited by 406
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of AmericaBiykem Bozkurt, Boback Ziaeian, Tariq Ahmad et al.|Journal of Cardiac Failure|2024Cited by 357